Thiesset Heather F, Schliep Karen C, Stokes Sean M, Valentin Virginia L, Gren Lisa H, Porucznik Christina A, Huang Lyen C
University of Utah Health Department of Surgery, Salt Lake City, Utah; Department of Family and Preventive Medicine, Division of Public Health, Salt Lake City, Utah.
Department of Family and Preventive Medicine, Division of Public Health, Salt Lake City, Utah.
J Surg Res. 2020 Aug;252:200-205. doi: 10.1016/j.jss.2020.03.015. Epub 2020 Apr 10.
A majority of surgical patients are prescribed opioids for pain management. Many patients have pre-existing chronic pain managed with opioids and/or opioid use disorders (OUDs), which can complicate perioperative management. Patients who use opioids prior to surgery are at increased risk of developing OUD after surgery. To date, no studies have examined the prevalence of opioid screening and electronic medical record (EMR) documentation prior to surgery.
A 40-item survey was administered to 268 patients at their first postoperative care visit at a single tertiary academic center from October 2017 to July 2018. A chart review of a random sample of 100 patients was performed to determine provider opioid screening prevalence in the presurgical setting. Log-binomial models were used to calculate prevalence ratios (PRs) to determine the provider role (surgeon, advanced practice clinicians [APC], surgical trainee) association with opioid screening documentation. Exploratory qualitative interviews were conducted with surgical providers to identify barriers to screening and screening documentation.
Only 7% of patients were screened preoperatively for opioid use. A total of 38% of patients self-reported that they had used opioids in the past year. Of that group, only 3% had screening by a surgical provider prior to surgery documented in their EMR. Provider role was not associated with likelihood of opioid screening (surgeon versus trainee, PR = 1.2, 95% CI 0.2-8.5) (surgeons versus APCs, PR = 1.05, 95% CI 0.17-8.53). EMRs were discordant with patient survey results for patients with no ICD-10 codes for opioid use. The most common perceived barriers to preoperative screening were insufficient clinic time; logistics of who should screen/not required as part of their clinical workflow; not perceiving screening as a priority; and lack of expertise in the area of chronic opioid use and OUD.
Preoperative screening for opioid use is uncommon, and EMRs are often discordant with patient self-reported use. Efforts to increase preoperative screening will need to address barriers screening practices and increasing health system support by incorporating screening into the clinical workflow and adding it to documentation templates.
大多数外科手术患者会被开具阿片类药物用于疼痛管理。许多患者术前就患有慢性疼痛,正在使用阿片类药物和/或患有阿片类药物使用障碍(OUD),这会使围手术期管理变得复杂。术前使用阿片类药物的患者术后发生阿片类药物使用障碍的风险增加。迄今为止,尚无研究调查术前阿片类药物筛查及电子病历(EMR)记录的普及率。
2017年10月至2018年7月期间,在一家三级学术中心,对268例患者进行了首次术后护理访视时进行了一项包含40个项目的调查。对100例患者的随机样本进行病历审查,以确定术前环境中医疗服务提供者阿片类药物筛查的普及率。使用对数二项模型计算患病率比(PR),以确定医疗服务提供者角色(外科医生、高级实践临床医生[APC]、外科实习生)与阿片类药物筛查记录之间的关联。对外科医疗服务提供者进行探索性定性访谈,以确定筛查及筛查记录的障碍。
仅7%的患者术前接受了阿片类药物使用筛查。共有38%的患者自我报告在过去一年中使用过阿片类药物。在该组患者中,其电子病历中记录的术前由外科医疗服务提供者进行筛查的仅占3%。医疗服务提供者角色与阿片类药物筛查可能性无关(外科医生与实习生,PR = 1.2,95%CI 0.2 - 8.5)(外科医生与APC,PR = 1.05,95%CI 0.17 - 8.53)。对于没有阿片类药物使用的ICD - 10编码的患者,电子病历与患者调查结果不一致。术前筛查最常见的感知障碍是门诊时间不足;谁应进行筛查/不属于其临床工作流程要求的后勤问题;不将筛查视为优先事项;以及缺乏慢性阿片类药物使用和OUD领域的专业知识。
术前阿片类药物使用筛查并不常见,且电子病历往往与患者自我报告的使用情况不一致。增加术前筛查的努力需要解决筛查实践中的障碍,并通过将筛查纳入临床工作流程并添加到文档模板中来增加卫生系统的支持。